Hiltzik: A small study of COVID vaccine aftereffects triggers a political and scientific storm
Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...
Moderna suffers setback in vaccine patent battle with Pfizer
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
mlive19h
Still ‘no red flags’ for COVID vaccine after years of monitoring their safety
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
IPWatchdog4d
Moderna COVID Vaccine Technology Struck Down by PTAB
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
STAT1d
Five years of Covid exacted a terrible toll. Another epidemic has claimed even more lives
The 2020s have inarguably been Covid-19’s decade. Since the coronavirus outbreak was acknowledged as a pandemic exactly five ...
5 years ago, the WHO declared COVID a pandemic. Here's a look at the disease by the numbers
Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...
JD Supra1d
COVID-19 Vaccine Patent War: Moderna's Claims Invalidated by PTAB
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...
Among public companies, Covid created both winners and losers
The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
Moderna's COVID sales have been declining, and the company has been trimming costs. But it doesn't have a huge growth ...
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...